BEKE-W
02423
MEITUAN-W
03690
JD-SW
09618
4
TRIP.COM-S
09961
5
TME-SW
01698
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | ---- | -3.65%11.69B | ---- | 350.02%12.13B | ---- | -80.46%2.7B | ---- |
Profit adjustment | ||||||||||
Revaluation surplus: | ---- | ---- | ---- | ---- | -141.95%-810M | ---- | -56.32%1.93B | ---- | 218.59%4.42B | ---- |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | -141.95%-810M | ---- | -56.32%1.93B | ---- | 218.59%4.42B | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | 77.32%-458M | ---- | -6.43%-2.02B | ---- | 21.32%-1.9B | ---- |
-Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---36M | ---- | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | -46.96%-363M | ---- | 87.81%-247M | ---- | -46.39%-2.03B | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | 101.83%4M | ---- | -1,111.11%-218M | ---- | 64.00%-18M | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | 93.48%-99M | ---- | -1,132.65%-1.52B | ---- | 115.05%147M | ---- |
Depreciation and amortization: | ---- | ---- | ---- | ---- | 7.09%4.68B | ---- | -52.57%4.37B | ---- | 19.65%9.21B | ---- |
-Depreciation | ---- | ---- | ---- | ---- | 7.09%4.68B | ---- | -52.57%4.37B | ---- | 19.65%9.21B | ---- |
Special items | ---- | ---- | ---- | ---- | 41.20%586M | ---- | 30.50%415M | ---- | 66.49%318M | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | ---- | -6.79%15.68B | ---- | 14.07%16.83B | ---- | -5.87%14.75B | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | -247.50%-2.09B | ---- | -204.90%-600M | ---- | 269.73%572M | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | ---- | -313.90%-774M | ---- | 83.48%-187M | ---- | -218.91%-1.13B | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | ---- | -62.17%830M | ---- | 372.84%2.19B | ---- | 119.27%464M | ---- |
Special items for working capital changes | ---- | ---- | ---- | ---- | 42.03%-1.61B | ---- | -691.28%-2.78B | ---- | 144.38%470M | ---- |
Cash from business operations | -13.12%12.58B | -26.35%5.31B | 20.23%14.48B | 17.23%7.21B | -22.07%12.04B | -42.32%6.15B | 2.18%15.45B | 105.89%10.66B | 18.00%15.12B | 18.50%5.18B |
Other taxs | 3.64%-2.06B | 6.92%-874M | 18.49%-2.14B | 30.80%-939M | -2.70%-2.63B | -16.98%-1.36B | -10.59%-2.56B | 19.89%-1.16B | -65.64%-2.31B | -45.82%-1.45B |
Dividend received - operating | 541.36%2.75B | 637.39%1.64B | -29.84%428M | -42.49%222M | -4.84%610M | 60.17%386M | 10.33%641M | -32.30%241M | -56.22%581M | -46.39%356M |
Interest received - operating | 27.77%658M | 51.27%298M | 73.99%515M | 75.89%197M | -8.07%296M | -6.67%112M | -31.78%322M | -56.83%120M | 18.89%472M | 115.50%278M |
Interest paid - operating | -2.91%-3.46B | -7.31%-1.65B | -55.33%-3.36B | -49.27%-1.53B | 1.23%-2.17B | 2.10%-1.03B | 8.82%-2.19B | 12.87%-1.05B | 7.65%-2.4B | 3.76%-1.2B |
Net cash from operations | 5.46%10.46B | -8.34%4.72B | 21.59%9.92B | 20.93%5.15B | -30.08%8.16B | -51.63%4.26B | 1.80%11.67B | 178.94%8.81B | 8.71%11.46B | 8.26%3.16B |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | 102.76%42M | 111.68%162M | -428.73%-1.52B | -1,316.67%-1.39B | 3.81%463M | 125.17%114M | -44.73%446M | -220.16%-453M | 155.31%807M | -40.25%377M |
Decrease in deposits (increase) | 405.33%854M | 237.16%753M | 158.68%169M | -276.03%-549M | 50.26%-288M | -586.67%-146M | -7,137.50%-579M | 36.36%30M | 38.46%-8M | 100.73%22M |
Sale of fixed assets | 152.27%835M | 211.47%679M | -52.37%331M | 153.49%218M | -72.35%695M | -77.55%86M | 191.65%2.51B | 12.32%383M | 184.49%862M | 140.14%341M |
Purchase of fixed assets | -28.19%-4.41B | -20.34%-2.07B | -10.50%-3.44B | -29.11%-1.72B | 18.31%-3.11B | 27.75%-1.33B | -34.99%-3.81B | -15.60%-1.85B | 25.33%-2.82B | 2.09%-1.6B |
Purchase of intangible assets | 2.53%-154M | 41.67%-42M | 49.68%-158M | -26.32%-72M | 22.47%-314M | 24.00%-57M | -128.81%-405M | 15.73%-75M | 75.95%-177M | 85.94%-89M |
Sale of subsidiaries | ---- | ---- | 2,017.61%30.43B | ---- | 38.17%1.44B | -6.07%449M | -88.98%1.04B | --478M | -52.89%9.43B | ---- |
Acquisition of subsidiaries | 44.12%-1.82B | 66.57%-833M | -82.56%-3.26B | ---2.49B | ---1.78B | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | -80.40%1.04B | 1,390.00%894M | 152.80%5.29B | -85.82%60M | -46.04%2.09B | -76.03%423M | 193.20%3.88B | 1,818.48%1.77B | 348.47%1.32B | -2.13%92M |
Cash on investment | 30.86%-9.94B | -126.61%-5.49B | 7.40%-14.38B | 58.87%-2.42B | -64.83%-15.53B | 9.04%-5.89B | -22.53%-9.42B | -506.08%-6.48B | -242.34%-7.69B | -20.25%-1.07B |
Other items in the investment business | -138.85%-1.04B | -164.16%-737M | 63.81%-435M | -89.80%-279M | -19,933.33%-1.2B | -7,250.00%-147M | -100.00%-6M | 33.33%-2M | 84.21%-3M | 82.35%-3M |
Net cash from investment operations | -212.03%-14.6B | 22.65%-6.69B | 174.28%13.03B | -32.93%-8.65B | -176.51%-17.54B | -4.94%-6.5B | -467.77%-6.34B | -221.97%-6.2B | -86.05%1.73B | -115.60%-1.93B |
Net cash before financing | -118.04%-4.14B | 43.74%-1.97B | 344.48%22.95B | -55.73%-3.49B | -276.40%-9.39B | -185.91%-2.24B | -59.64%5.32B | 111.76%2.61B | -42.45%13.18B | -91.92%1.23B |
Cash flow from financing activities | ||||||||||
New borrowing | 57.59%36.97B | 16.78%15.77B | -8.62%23.46B | 24.46%13.51B | 426.26%25.68B | 376.22%10.85B | -66.41%4.88B | -82.83%2.28B | 37.50%14.53B | 134.41%13.27B |
Refund | 50.93%-12.7B | 19.12%-3.69B | -37.21%-25.89B | 69.71%-4.56B | -59.54%-18.87B | -103.74%-15.04B | 17.85%-11.83B | 21.80%-7.38B | -1.84%-14.4B | -21.73%-9.44B |
Dividends paid - financing | 65.19%-6.12B | -6.38%-3.93B | -208.50%-17.57B | -13.37%-3.7B | -28.72%-5.7B | -36.67%-3.26B | 9.38%-4.43B | 28.99%-2.39B | 18.29%-4.88B | 6.38%-3.36B |
Absorb investment income | 300.00%64M | --33M | -98.40%16M | ---- | --1B | --986M | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | -355.70%-3.88B | -193.27%-2.01B | 67.75%-851M | ---684M | ---2.64B | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | ---755M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | 158.09%12.62B | 38.29%5.71B | -1,449.64%-21.73B | 159.61%4.13B | 88.64%-1.4B | 12.88%-6.92B | -116.98%-12.34B | -99,412.50%-7.95B | 46.10%-5.69B | 100.13%8M |
Effect of rate | -231.76%-491M | 13.50%-237M | 84.79%-148M | 44.31%-274M | -416.94%-973M | -469.92%-492M | -26.02%307M | 200.76%133M | 400.72%415M | -325.81%-132M |
Net Cash | 594.59%8.48B | 491.00%3.74B | 111.32%1.22B | 106.91%633M | -53.65%-10.79B | -71.82%-9.17B | -193.66%-7.02B | -529.81%-5.33B | -39.34%7.5B | -86.00%1.24B |
Begining period cash | 9.97%11.83B | 9.97%11.83B | -52.23%10.76B | -52.23%10.76B | -22.97%22.52B | -22.97%22.52B | 37.10%29.23B | 37.10%29.23B | 134.26%21.32B | 134.26%21.32B |
Cash at the end | 67.53%19.82B | 37.94%15.34B | 9.97%11.83B | -13.57%11.12B | -52.23%10.76B | -46.48%12.86B | -22.97%22.52B | 7.14%24.03B | 37.10%29.23B | 25.08%22.43B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.